American Heart Journal
Volume 158, Issue 4 , Pages 506-508 , October 2009

The high cost of nonadherence after percutaneous coronary intervention—Can health care reform solve this problem?

Received 7 July 2009 ,Accepted 13 July 2009.

References 

  1. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813–818
  2. Pallares MJ, Powers ER, Zwerner PL, et al. Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009;43:259–267
  3. Policy Statement On Healthcare Reform, Its implementation, and Future Innovations, May 28, 2009: National Conference of Pharmaceutical Organizations; 2009.
  4. Cross J. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient. Am J Manag Care. 2009;15(2 Suppl):S48–S53
  5. Ko D, Chiu M, Guo H, et al. Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents. Am Heart J. 2009;158:592–598
  6. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497
  7. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105–116
  8. Simpson RJ. Challenges for improving medication adherence. JAMA. 2006;296:2614–2616
  9. Mukherjee D. Improving adherence to medications—can we make this horse drink?. Am Heart J. 2008;155:589–590
  10. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296:2563–2571
  11. Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300:2514–2526
  12. O'Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med. 2006;166:1802–1804

PII: S0002-8703(09)00544-4

doi: 10.1016/j.ahj.2009.07.007

American Heart Journal
Volume 158, Issue 4 , Pages 506-508 , October 2009

Article Tools